Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on April 10, 2025
Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
GlobeNewswire
·
April 10, 2025
DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …
Eviden signs a 50-million-euro contract to build Serbia’s National AI Factory
GlobeNewswire
·
April 10, 2025
Eviden will bring together a unique comprehensive set of AI capabilities – supercomputing power for AI, software layer and AI use-cases development Paris, France – April 10, 2025 – Eviden, the Atos Group business leading in digital, cloud, big data and …
Eviden signe un contrat de 50 millions d'euros pour développer une « AI Factory » nationale en Serbie
GlobeNewswire
·
April 10, 2025
Eviden fournira un ensemble complet et unique de capacités d'IA associant puissance de supercalcul, couche logicielle et développement de cas d’usage d’IA Paris, France – 10 avril 2025 – Eviden, la ligne d’activités du groupe Atos leader dans le digital, …
Advanced PMIC for High-Performance AI, Industrial Computing and Data Center Applications
GlobeNewswire
·
April 10, 2025
CHANDLER, Ariz., April 10, 2025 (GLOBE NEWSWIRE) -- The rapid integration of AI into industrial, computing and data center applications is fueling a growing demand for more efficient and advanced power management solutions. Microchip Technology (Nasdaq: …
Vertex baut sein Chief Strategy Office aus, um e-Invoicing und globale Compliance-Initiativen voranzutreiben
GlobeNewswire
·
April 10, 2025
KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX), ein globaler Anbieter von Technologielösungen für indirekte Steuern, gab heute die Erweiterung seines Chief Strategy Office (CSO) bekannt: Christopher Hall und Kathya …
Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives
GlobeNewswire
·
April 10, 2025
KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced the expansion of its Chief Strategy Office (CSO) with the addition of …
Avalyn to Participate in Upcoming Investor Conference in April
GlobeNewswire
·
April 10, 2025
CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will …
Juve Stabia's International Profile Grows with U.S., Canada & U.K. Live Broadcast of Sunday’s Match vs. Cremonese
GlobeNewswire
·
April 10, 2025
S.S. Juve Stabia’s upcoming Serie B fixture against Cremonese will be broadcast in English live and free in the United States, Canada and United Kingdom via Destination Calcio Dublin, Ireland and Milan, Italy, April 10, 2025 (GLOBE NEWSWIRE) -- Brera …
Global Clean Technology Innovators Honored in 2025 CleanTech Breakthrough Awards Program
GlobeNewswire
·
April 10, 2025
LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- CleanTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout climate and clean technology companies, products and services around the globe, today …
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …
NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET
GlobeNewswire
·
April 10, 2025
HOLLYWOOD, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of tech-enabled engineering, certification, and consulting solutions, will announce its financial results for the first quarter ended …
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire
·
April 10, 2025
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need …
Janover Purchases Approximately $4.6 Million of Solana (SOL) as Part of New Treasury Strategy
GlobeNewswire
·
April 10, 2025
BOCA RATON, FL, April 10, 2025 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”) announced today the purchase of approximately $4.6 million Solana (SOL) — the first execution under its newly adopted digital asset treasury …
Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis
GlobeNewswire
·
April 10, 2025
– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a patient survey conducted in partnership with the National …
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire
·
April 10, 2025
Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes …
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
GlobeNewswire
·
April 10, 2025
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …
Byrna Technologies Fiscal First Quarter 2025 Results
GlobeNewswire
·
April 10, 2025
ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
GlobeNewswire
·
April 10, 2025
Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), a leader in blood volume measurement technology, announces today the submission of its next-generation blood …
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China
GlobeNewswire
·
April 10, 2025
FREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has been …
Willis appoints Dom Spinelli Head of Transactional Insurance Claims in North America
GlobeNewswire
·
April 10, 2025
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Willis, a WTW business (Nasdaq: WTW), today announced the appointment of Dom Spinelli as Head of Transactional Insurance Claims for North America. In this role, he will lead the claims function within Willis’ …